Malaysia Proposes Biosimilars Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
Southeast Asia nation may be first in the area to regulate FOBs, but local companies aren’t ready to produce, analyst says.
You may also be interested in...
Japan Posts Draft Guidance On Biosimilars; Seeks Public Comment
TOKYO - Japan's Ministry of Health, Labor and Welfare Sept. 17 posted draft guidance on follow-on biologics, or biosimilars, a move that could make Japan among the first group of large economies to set a safety and regulatory framework for the new copycat breed of biologic therapies
New EPO Products Set To Boost Future Revenue For 3SBio
SHANGHAI - 3SBio generated revenues from increased sales of its recombinant human erythropoietin products but saw its earnings slip, according to the unaudited financial results for the second quarter ended June 30
Global Drug Regulators And Manufacturers Grapple With How To Ensure Global Quality Standards (Part 2 Of 2)
[Editor's note: This is part two of a two-part feature on ensuring drug quality, as discussed at the Fifth IFPMA Asian Regulatory Conference in Kuala Lumpur. Part one appeared in PharmAsia News, March 17, 2008.]